Successful pregnancy possible after kidney transplant
October 20, 2011 in OtherA new study recently published in the American Journal of Transplantation reveals that the ability to successfully carry a pregnancy after kidney transplantation is very high, with 73.5% live birth rates.
Researchers led by Dorry Segev, MD, PhD, of Johns Hopkins University performed a systematic review and meta-analysis of articles published between 2000 and 2010 that reported pregnancy-related outcomes among KT recipients.
Results found that a successful pregnancy is possible after receiving a kidney transplant, although the relatively high rate of medical complications of the pregnancy motivates very careful monitoring.
Women who become pregnant after kidney transplantation have relatively high rates of pregnancy complications, such as preeclampsia, gestational diabetes, and preterm delivery.
Pregnancy complications are particularly higher among those women who become pregnant within two years of having the kidney transplant; complication rates fall up to 50% in studies where the mean interval between the transplant and the pregnancy was more than two years.
An accompanying editorial by V.T. Armenti of Thomas Jefferson University also emphasizes that the risks of pregnancy are not going to go away; they are inherent in the transplant population and ultimately the patient must be given the opportunity to make the decision.
"First, our findings inform the clinical decision-making process for women of childbearing age deciding whether to pursue kidney transplantation (as opposed to remaining on dialysis)," Segev notes. "Second, our findings motivate careful follow-up of pregnant women who are kidney transplant recipients."
Provided by
Wiley
-
Pregnancy and birth: Safe for women with kidney transplants
Sep 24, 2009 |
not rated yet |
0
-
Older women less likely than men to be listed for kidney transplants
Jan 13, 2009 |
not rated yet |
0
-
Women's access to donated kidneys declines with age, particularly compared with men
Jan 07, 2009 |
not rated yet |
0
-
New clinical prediction index to help patients considering kidney transplant
Mar 29, 2010 |
not rated yet |
0
-
Anti-rejection drug may increase risk of diabetes after kidney transplant
May 22, 2008 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Other
7 hours ago |
not rated yet |
0
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Other
22 hours ago |
1 / 5 (1) |
0
|
Neck strength, cervical spine mobility don't predict pain
(HealthDay) -- Neither isometric neck muscle strength nor passive mobility of the cervical spine, two physical capacity parameters found to be associated with neck pain in other studies, predicts later neck ...
Other
May 25, 2012 |
not rated yet |
0
Pool access for the disabled sparks controversy
(AP) -- The Obama administration is sidestepping an election-year confrontation with the hotel industry and other pool owners to give them more time to comply with access rules for the disabled.
Other
May 25, 2012 |
not rated yet |
0
Chile to cover sex change operations
Chile will soon cover sex change surgeries under its public health plan in order to allow citizens of limited means to "recover their true sexual identity," Health Minister Jaime Manalich said.
Other
May 25, 2012 |
not rated yet |
0
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Most occupational injury and illness costs are paid by the government and private payers
UC Davis researchers have found that workers' compensation insurance is not used nearly as much as it should be to cover the nation's multi-billion dollar price tag for workplace illnesses and injuries. Instead, almost 80 ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.